EVOTEC Aktie [WKN: 566480 / ISIN: DE0005664809]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Orderbuch	Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu EVOTEC SE

13.08.24		EQS-News: Evotec verkündet starke Fortschritte in strategischer Partnerschaft mit Bristol Myers Squibb im Bereich Protein Degradation (EQS Group)
09.08.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
08.08.24		EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb (EQS Group)
08.08.24		EQS-News: Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb (EQS Group)
07.08.24		EQS-News: Evotec SE berichtet Ergebnisse für das erste Halbjahr 2024 am 14. August 2024 (EQS Group)
07.08.24		EQS-News: Evotec SE reports first half-year 2024 results on 14 August 2024 (EQS Group)
06.08.24		EQS-News: Evotec provides guidance update (EQS Group)
06.08.24		EQS-News: Evotec gibt Prognose Update bekannt (EQS Group)
23.07.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
11.07.24		EQS-NVR: Evotec SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
11.07.24		EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
10.07.24		EQS-News: Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen (EQS Group)
10.07.24		EQS-News: Evotec and Pfizer collaborate to advance drug discovery in France (EQS Group)
08.07.24		EQS-News: Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz (EQS Group)
08.07.24		EQS-News: Just – Evotec Biologics erweitert Tech-Partnerschaft für Biosimilars mit Sandoz (EQS Group)
05.07.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
04.07.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
01.07.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.06.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
26.06.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
25.06.24		EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program (EQS Group)
25.06.24		EQS-News: Just – Evotec Biologics vom US-amerikanischen Verteidigungsministerium für Manufacturing Optimization Program ausgewählt (EQS Group)
12.06.24		EQS-News: Evotec gibt Fortschritt in Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt (EQS Group)
12.06.24		EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb (EQS Group)
10.06.24		EQS-News: Evotec SE: Ergebnisse der Hauptversammlung 2024 (EQS Group)
10.06.24		EQS-News: Evotec SE: Results of the Annual General Meeting 2024 (EQS Group)
04.06.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.05.24		EQS-News: Evotec, Inserm, Lille University Hospital und Inserm Transfert arbeiten zusammen, um neue therapeutische Ziele bei Adipositas und Stoffwechselerkrankungen zu identifizieren (EQS Group)
30.05.24		EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases (EQS Group)
28.05.24		EQS-News: Evotec und CHDI Foundation verlängern strategische Huntington-Allianz (EQS Group)
28.05.24		EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease (EQS Group)
27.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
22.05.24		EQS-News: Evotec reports Q1 2024 results and provides corporate update (EQS Group)
22.05.24		EQS-News: Evotec SE: Ergebnisse für das erste Quartal 2024 und Update zur Unternehmensentwicklung (EQS Group)
21.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
16.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.05.24		EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024 (EQS Group)
15.05.24		EQS-News: Evotec SE: Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024 (EQS Group)
14.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
14.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
13.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
08.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
06.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
03.05.24		EQS-DD: Evotec SE: Dr. Cord Dohrmann, Gesperrte Aktien gewährt als kurzfristige variable Vergütung (Bonus) für 2023 gemäß Evotecs Vergütungssystem. (EQS Group)
03.05.24		EQS-DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system. (EQS Group)
03.05.24		EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)

Zurück | 1 | 2 | Weiter

Newssuche

EVOTEC Peer Group Nachrichten

18:02		Zuversicht in New York: Dow Jones mit Kursplus
17:59		Börse Europa: STOXX 50 beendet den Mittwochshandel im Plus
17:59		Börse Zürich in Grün: SMI beendet den Mittwochshandel in der Gewinnzone
17:59		SLI aktuell: Schlussendlich Gewinne im SLI
17:59		Mittwochshandel in Frankfurt: SDAX notiert schlussendlich im Plus
17:59		Mittwochshandel in London: FTSE 100 letztendlich stärker
17:59		Aufschläge in Zürich: SPI letztendlich freundlich
17:59		Angespannte Stimmung in Frankfurt: TecDAX beendet den Handel in der Verlustzone

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	11.12.2024 22:26
Kaufwert:	EUR
	Hinzufügen Speichern

EVOTEC Aktie [WKN: 566480 / ISIN: DE0005664809]

Nachrichten zu EVOTEC SE

Newssuche

EVOTEC Peer Group Nachrichten

Meistgelesene Nachrichten